Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer

PURPOSE Breast cancer is the most common cancer in women in India, with higher incidence rates of aggressive subtypes, such as triple-negative breast cancer (TNBC). METHODS A systematic review was performed to compute pooled prevalence rates of TNBC among patients with breast cancer, and clinical fe...

Full description

Bibliographic Details
Main Authors: Apurv Kulkarni, Devaki A. Kelkar, Nidhi Parikh, Lingadahalli S. Shashidhara, Chaitanyanand B. Koppiker, Madhura Kulkarni
Format: Article
Language:English
Published: American Society of Clinical Oncology 2020-11-01
Series:JCO Global Oncology
Online Access:https://ascopubs.org/doi/10.1200/GO.20.00054
_version_ 1818357818638467072
author Apurv Kulkarni
Devaki A. Kelkar
Nidhi Parikh
Lingadahalli S. Shashidhara
Chaitanyanand B. Koppiker
Madhura Kulkarni
author_facet Apurv Kulkarni
Devaki A. Kelkar
Nidhi Parikh
Lingadahalli S. Shashidhara
Chaitanyanand B. Koppiker
Madhura Kulkarni
author_sort Apurv Kulkarni
collection DOAJ
description PURPOSE Breast cancer is the most common cancer in women in India, with higher incidence rates of aggressive subtypes, such as triple-negative breast cancer (TNBC). METHODS A systematic review was performed to compute pooled prevalence rates of TNBC among patients with breast cancer, and clinical features at presentation were systematically compared with non-TNBC in an Indian cohort of 20,000 patients. RESULTS Combined prevalence of TNBC among patients with breast cancer was found to be on the higher side (27%; 95% CI, 24% to 31%). We found that the estrogen receptor (ER) expression cutoff used to determine ER positivity had an influence on the pooled prevalence and ranged from 30% (ER/progesterone receptor [PR] cut ff at 1%) to 24% (ER/PR cutoff at 10%). Odds for TNBC to present in the younger age-group were significantly higher (pooled odds ratio [OR], 1.35; 95% CI, 1.08 to 1.69), with a significantly younger mean age of incidence (weighted mean difference, −2.75; 95% CI, −3.59 to −1.92). TNBC showed a significantly higher odds of presenting with high grade (pooled OR, 2.57; 95% CI, 2.12 to 3.12) and lymph node positivity (pooled OR, 1.39; 95% CI, 1.21 to 1.60) than non-TNBC. CONCLUSION Systematic review and meta-analysis of 34 studies revealed a high degree of heterogeneity in prevalence of TNBC within Indian patients with breast cancer, yet pooled prevalence of TNBC is high in India. High proportions of patients with TNBC present with aggressive features, such as high grade and lymph node positivity, compared with patients without TNBC. We emphasize the need for standardized methods for accurate diagnosis in countries like India.
first_indexed 2024-12-13T20:19:09Z
format Article
id doaj.art-792595dcfd964e0ba9e1f77c4891d56f
institution Directory Open Access Journal
issn 2687-8941
language English
last_indexed 2024-12-13T20:19:09Z
publishDate 2020-11-01
publisher American Society of Clinical Oncology
record_format Article
series JCO Global Oncology
spelling doaj.art-792595dcfd964e0ba9e1f77c4891d56f2022-12-21T23:32:44ZengAmerican Society of Clinical OncologyJCO Global Oncology2687-89412020-11-0161052106210.1200/GO.20.00054Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast CancerApurv Kulkarni0Devaki A. Kelkar1Nidhi Parikh2Lingadahalli S. Shashidhara3Chaitanyanand B. Koppiker4Madhura Kulkarni5Indian Institute of Science Education and Research, Pune, IndiaPrashanti Cancer Care Mission, Pune, IndiaIndian Institute of Science Education and Research, Pune, IndiaIndian Institute of Science Education and Research, Pune, IndiaPrashanti Cancer Care Mission, Pune, IndiaPrashanti Cancer Care Mission, Pune, IndiaPURPOSE Breast cancer is the most common cancer in women in India, with higher incidence rates of aggressive subtypes, such as triple-negative breast cancer (TNBC). METHODS A systematic review was performed to compute pooled prevalence rates of TNBC among patients with breast cancer, and clinical features at presentation were systematically compared with non-TNBC in an Indian cohort of 20,000 patients. RESULTS Combined prevalence of TNBC among patients with breast cancer was found to be on the higher side (27%; 95% CI, 24% to 31%). We found that the estrogen receptor (ER) expression cutoff used to determine ER positivity had an influence on the pooled prevalence and ranged from 30% (ER/progesterone receptor [PR] cut ff at 1%) to 24% (ER/PR cutoff at 10%). Odds for TNBC to present in the younger age-group were significantly higher (pooled odds ratio [OR], 1.35; 95% CI, 1.08 to 1.69), with a significantly younger mean age of incidence (weighted mean difference, −2.75; 95% CI, −3.59 to −1.92). TNBC showed a significantly higher odds of presenting with high grade (pooled OR, 2.57; 95% CI, 2.12 to 3.12) and lymph node positivity (pooled OR, 1.39; 95% CI, 1.21 to 1.60) than non-TNBC. CONCLUSION Systematic review and meta-analysis of 34 studies revealed a high degree of heterogeneity in prevalence of TNBC within Indian patients with breast cancer, yet pooled prevalence of TNBC is high in India. High proportions of patients with TNBC present with aggressive features, such as high grade and lymph node positivity, compared with patients without TNBC. We emphasize the need for standardized methods for accurate diagnosis in countries like India.https://ascopubs.org/doi/10.1200/GO.20.00054
spellingShingle Apurv Kulkarni
Devaki A. Kelkar
Nidhi Parikh
Lingadahalli S. Shashidhara
Chaitanyanand B. Koppiker
Madhura Kulkarni
Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer
JCO Global Oncology
title Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer
title_full Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer
title_fullStr Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer
title_full_unstemmed Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer
title_short Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer
title_sort meta analysis of prevalence of triple negative breast cancer and its clinical features at incidence in indian patients with breast cancer
url https://ascopubs.org/doi/10.1200/GO.20.00054
work_keys_str_mv AT apurvkulkarni metaanalysisofprevalenceoftriplenegativebreastcanceranditsclinicalfeaturesatincidenceinindianpatientswithbreastcancer
AT devakiakelkar metaanalysisofprevalenceoftriplenegativebreastcanceranditsclinicalfeaturesatincidenceinindianpatientswithbreastcancer
AT nidhiparikh metaanalysisofprevalenceoftriplenegativebreastcanceranditsclinicalfeaturesatincidenceinindianpatientswithbreastcancer
AT lingadahallisshashidhara metaanalysisofprevalenceoftriplenegativebreastcanceranditsclinicalfeaturesatincidenceinindianpatientswithbreastcancer
AT chaitanyanandbkoppiker metaanalysisofprevalenceoftriplenegativebreastcanceranditsclinicalfeaturesatincidenceinindianpatientswithbreastcancer
AT madhurakulkarni metaanalysisofprevalenceoftriplenegativebreastcanceranditsclinicalfeaturesatincidenceinindianpatientswithbreastcancer